Lipoprotein Abnormalities in Patients with Atherosclerotic Renovascular Disease
Author(s) -
Elzbieta Nowakowska- Fortuna,
Hans Herlitz,
Aso Saeed,
Per-Ola Attman,
Gert Jensen,
Petar Alaupovic,
Gregor Guron
Publication year - 2011
Publication title -
kidney and blood pressure research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.806
H-Index - 51
eISSN - 1423-0143
pISSN - 1420-4096
DOI - 10.1159/000325648
Subject(s) - medicine , candesartan , endocrinology , lipoprotein , apolipoprotein b , lipoprotein(a) , triglyceride , angiotensin ii , cardiology , cholesterol , gastroenterology , blood pressure
Patients with atherosclerotic renovascular disease (ARVD) have a high risk of cardiovascular death. The primary aim was to characterize abnormalities in apolipoprotein (Apo)-defined lipoprotein (Lp) subclasses in patients with ARVD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom